These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7871492)

  • 1. N,N,N-trimethylsphingosine modifies aggregatory response and ATP release from platelets in whole blood.
    Knöfler R; Urano T; Takada Y; Takada A
    Thromb Res; 1994 Nov; 76(4):323-32. PubMed ID: 7871492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of GMP-140 (CD62 or PADGEM) expression on platelets by N,N-dimethyl and N,N,N-trimethyl derivatives of sphingosine.
    Handa K; Igarashi Y; Nisar M; Hakomori S
    Biochemistry; 1991 Dec; 30(50):11682-6. PubMed ID: 1721534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole blood platelet aggregation in humans and animals: a comparative study.
    Soloviev MV; Okazaki Y; Harasaki H
    J Surg Res; 1999 Apr; 82(2):180-7. PubMed ID: 10090827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of endothelin-1 on aggregation of normal and uremic platelets.
    Pawlak K; Małyszko JS; Małyszko J; Myśliwiec M
    Pol J Pharmacol; 1996; 48(2):185-90. PubMed ID: 9112649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL; Packham MA
    Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine inhibition of agonist-dependent secretion and activation of human platelets implies that protein kinase C is a necessary and common event of the signal transduction pathways.
    Hannun YA; Greenberg CS; Bell RM
    J Biol Chem; 1987 Oct; 262(28):13620-6. PubMed ID: 3115982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell membrane signaling as target in cancer therapy. II: Inhibitory effect of N,N,N-trimethylsphingosine on metastatic potential of murine B16 melanoma cell line through blocking of tumor cell-dependent platelet aggregation.
    Okoshi H; Hakomori S; Nisar M; Zhou QH; Kimura S; Tashiro K; Igarashi Y
    Cancer Res; 1991 Nov; 51(22):6019-24. PubMed ID: 1657377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen-induced platelet aggregation:--evidence against the essential role of platelet adenosine diphosphate.
    Nunn B
    Thromb Haemost; 1979 Dec; 42(4):1193-206. PubMed ID: 542929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
    Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
    Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of streptozocin-induced diabetes on platelet aggregation as determined by impedance aggregometry and platelet secretion: a possible role for nitric oxide.
    Judge S; Mammen E; Dunbar JC
    J Assoc Acad Minor Phys; 1995; 6(3):100-4. PubMed ID: 7663098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostasis, platelet function and serotonin in acute and chronic renal failure.
    Malyszko J; Malyszko JS; Pawlak D; Pawlak K; Buczko W; Mysliwiec M
    Thromb Res; 1996 Sep; 83(5):351-61. PubMed ID: 8873344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by diisoeugenol.
    Lin CH; Kuo YH; Lin YL; Teng CM
    J Pharm Pharmacol; 1994 Jan; 46(1):54-7. PubMed ID: 8201527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man.
    May JA; Heptinstall S; Cole AT; Hawkey CJ
    Thromb Res; 1997 Oct; 88(2):183-92. PubMed ID: 9361371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species variability in platelet aggregation response to different agonists.
    Pelagalli A; Lombardi P; d'Angelo D; Della Morte R; Avallone L; Staiano N
    J Comp Pathol; 2002; 127(2-3):126-32. PubMed ID: 12354523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparin as an anticoagulant for in vitro platelet function studies.
    van Wyk V; Heyns AD
    Thromb Res; 1990 Feb; 57(4):601-9. PubMed ID: 2158153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weak inhibition of protein kinase C coupled with various non-specific effects make sphingosine an unsuitable tool in platelet signal transduction studies.
    Krishnamurthi S; Patel Y; Kakkar VV
    Biochim Biophys Acta; 1989 Feb; 1010(2):258-64. PubMed ID: 2492201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway.
    Sturk A; Asyee GM; Schaap MC; van Maanen M; ten Cate JW
    Thromb Res; 1985 Nov; 40(3):359-72. PubMed ID: 2934863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet aggregation inhibiting activity of human placental chorioepithelial brush border membrane vesicles.
    Iioka H; Akada S; Shimamoto T; Yamada Y; Sakamoto Y; Moriyama SI; Ichijo M
    Placenta; 1993; 14(1):75-83. PubMed ID: 8456091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelet aggregation by moxalactam and free N-methylthiotetrazole.
    Ingalls CS; Somani P; Freimer EH
    Clin Ther; 1989; 11(5):640-51. PubMed ID: 2629724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.